BM
BMY
Latest · Mar 31, 2026
Quarter ended Mar 31, 2026 · FY2026 Q1

Bristol-Myers Squibb Company stock research

Bristol-Myers Squibb (BMY) Free Cash Flow — Quarter Ended Mar 31, 2026

Revenue was lower than the prior quarter but slightly higher than a year ago. Free cash flow and free cash flow margin weakened compared to both the preceding quarter and the same quarter last year.

Free cash flow takeaway

A quick read on the company's cash generation and what it means for investors.

Revenue was lower than the prior quarter but slightly higher than a year ago. Free cash flow and free cash flow margin weakened compared to both the preceding quarter and the same quarter last year.

  • Operating cash flow was lower than both the prior quarter and the year-ago quarter, while capital expenditure was higher than a year ago but slightly lower than the prior quarter. The resulting free cash flow and free cash flow margin were lower than both comparison periods, indicating a weakened cash conversion rate.
  • Compared to the immediately preceding quarter, revenue, operating cash flow, free cash flow, and free cash flow margin were all lower. Compared to the same quarter one year earlier, revenue was slightly higher, but operating cash flow, free cash flow, and free cash flow margin were all lower.

FCF snapshot

Quarterly and TTM cash-flow metrics with the minimum valuation context.

TTM free cash flow

$11.9B

Trailing twelve-month free cash flow.

Quarter free cash flow

$757.0M

Free cash flow in the selected fiscal quarter.

Operating cash flow

$1.1B

Cash generated by operations before capital spending.

CapEx

$347.0M

Capital spending and related asset purchases.

FCF margin

6.6%

The share of revenue converted into free cash flow.

TTM FCF yield

10.2%

TTM FCF divided by market capitalization.

Cash flow trend

A short quarterly history shows whether FCF is scaling with revenue or only spiking for one period.

PeriodRevenueOperating CFCapExFCFFCF margin
2025-06-30$12.3B$3.9B$361.0M$3.6B29.0%
2025-09-30$12.2B$6.3B$320.0M$6.0B49.0%
2025-12-31$12.5B$2.0B$370.0M$1.6B12.8%
2026-03-31$11.5B$1.1B$347.0M$757.0M6.6%

Cash conversion quality

Checks that separate high-quality free cash flow from accounting noise or working-capital timing.

FCF / net income28.3%Shows whether accounting earnings convert into cash.
CapEx / revenue3.0%Lower capital intensity usually supports FCF margin.
Net cash-$34.6BCash and equivalents minus total debt.

Recent events shaping cash flow

Near-term business events that help explain the free cash flow result.

Watch

Operating Cash Flow Decline

Operating cash flow was lower than both the prior quarter and the year-ago quarter, despite revenue being slightly higher than a year ago. This was the strongest observable driver of the weakened free cash flow.

The lower operating cash flow directly reduced free cash flow and free cash flow margin compared to both prior periods.

What the cash flow says

How to interpret the company's free cash flow beyond the headline number.

Operating cash flow was lower than both the prior quarter and the year-ago quarter, while capital expenditure was higher than a year ago but slightly lower than the prior quarter. The resulting free cash flow and free cash flow margin were lower than both comparison periods, indicating a weakened cash conversion rate.

Compared to the immediately preceding quarter, revenue, operating cash flow, free cash flow, and free cash flow margin were all lower. Compared to the same quarter one year earlier, revenue was slightly higher, but operating cash flow, free cash flow, and free cash flow margin were all lower.

Monitor the trajectory of operating cash flow, as it declined from both the prior quarter and the year-ago quarter while revenue remained relatively stable.

Valuation context

A cash-flow page should show how much investors are paying for the cash stream, without turning into a full DCF.

Market capitalization$116.3BUsed as the denominator for FCF yield.
TTM FCF yield10.2%TTM free cash flow divided by market capitalization.
EV / TTM FCF12.7xA quick valuation bridge, not a full DCF.

Peer context

Free cash flow quality is easier to read against related public companies.

BM
BMY

Bristol-Myers Squibb Company

FCF margin

6.6%

FCF yield

10.2%